Cargando…

2225. Analysis of Co-Resistance Among Escherichia coli Urine Isolates From Female Outpatients in the United States

BACKGROUND: In the past 10 years, there has been a substantial increase in antimicrobial resistance among uropathogens in community-acquired uncomplicated urinary tract infections (uUTIs), including extended spectrum β-lactamase producing (ESBL+) Enterobacterales and multidrug resistance. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaye, Keith S, Gupta, Vikas, Mulgirigama, Aruni, Joshi, Ashish V, Scangarella-Oman, Nicole E, Yu, Kalvin, Watts, Janet, Mitrani-Gold, Fanny S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753003/ http://dx.doi.org/10.1093/ofid/ofac492.1844

Ejemplares similares

2226. Analysis of Co-Resistance Among Klebsiella pneumoniae Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022)

187. Regional Distribution of Antimicrobial Resistance Among Outpatient Urine e. Coli Isolates in US Females ≥12 Years of age: a Multicenter Evaluation in 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

1698. Trends in antimicrobial resistance among outpatient urine E. coli isolates in US females ≥12 years of age: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management
por: Kaye, Keith S, et al.
Publicado: (2021)

Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients
por: Mitrani-Gold, Fanny S., et al.
Publicado: (2023)

1699. Variation of antimicrobial resistance by age groups for outpatient UTI isolates in US females: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study
por: Naber, Kurt G., et al.
Publicado: (2023)

A systematic scoping review of faropenem and other oral penems: treatment of Enterobacterales infections, development of resistance and cross-resistance to carbapenems
por: Gandra, Sumanth, et al.
Publicado: (2022)

714. Analysis of the Effect of Urine on the In Vitro Activity of Gepotidacin and Levofloxacin Against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus
por: Koeth, Laura M, et al.
Publicado: (2019)

P19 Burden of illness and costs among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

P17 Baseline characteristics, disease progression rates and risk factors among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

P18 Treatment patterns and extent of inappropriate antimicrobial treatment among female patients with uncomplicated urinary tract infection in England
por: Wilcox, Mark, et al.
Publicado: (2023)

Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review
por: Stapleton, Ann E., et al.
Publicado: (2020)

1262. Antimicrobial Activity of Gepotidacin against Clinical Isolates of Escherichia coli and Staphylococcus saprophyticus Collected Worldwide in 2019
por: Arends, S J Ryan, et al.
Publicado: (2020)

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)
por: Arends, S. J. Ryan, et al.
Publicado: (2023)

2159. Analysis of Resistance to Oral Standard-of-Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected in the United States in 2022
por: Arends, S J Ryan, et al.
Publicado: (2023)

PReS-FINAL-2225: Oxidative stress in children with episodic fever of unknown origin
por: Vojinovic, J, et al.
Publicado: (2013)

194. Progression of an Uncomplicated Urinary Tract Infection Among Female Patients with Susceptible and Non-Susceptible Urine Isolates: Findings from an Integrated Delivery Network
por: Shafrin, Jason, et al.
Publicado: (2021)

2237. Enterbacterales Resistance Patterns for Extended-spectrum beta-lactamases (ESBL) Positive and Multidrug Resistance (MDR) Urine Isolates Collected and Tested from 295 Outpatient US Facilities in 2019
por: Rodriguez, Mauricio, et al.
Publicado: (2022)

1062. Analysis of Resistance to Oral Standard of Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected Worldwide between 2019-2020
por: Arends, S J Ryan, et al.
Publicado: (2021)

2225. Implementing Updated Intraamniotic Infection Guidelines at a Large Academic Medical Center
por: Smiley, Casey, et al.
Publicado: (2023)

186. A Systematic Literature Review on the Economic Burden of Illness in Gonorrhea
por: Martin, Amber, et al.
Publicado: (2020)

1358. A Real-World Study of the Burden of Illness and Treatment Patterns Among Patients with Uncomplicated Urogenital Gonorrhea in the United States
por: Preib, Madison T, et al.
Publicado: (2021)

1414. Real-World Study of Healthcare Resource Use and Costs Associated with Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the United States
por: Preib, Madison T, et al.
Publicado: (2021)

1415. Allergies to Antimicrobial Agents Among US Females with Uncomplicated Urinary Tract Infection
por: Thompson, Jeffrey, et al.
Publicado: (2021)

1227. A Survey Study of Healthcare Resource Use, and Direct and Indirect Costs, Among Females with an Uncomplicated Urinary Tract Infection in the United States
por: Thompson, Jeffrey, et al.
Publicado: (2021)

196. Activity Impairment and Health-Related Quality of Life Associated with an Uncomplicated Urinary Tract Infection Among US Females
por: Thompson, Jeffrey, et al.
Publicado: (2021)

Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United States
por: Thompson, Jeffrey, et al.
Publicado: (2023)

Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems
por: VanScoy, Brian D., et al.
Publicado: (2021)

2225. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-Analysis
por: Jasper, Annie S, et al.
Publicado: (2019)

1075. In vitro Activity of Gepotidacin against Escherichia coli Causing Urinary Tract Infections in the United States, Including Molecularly Characterized Fluoroquinolone Resistant Subsets
por: Mendes, Rodrigo E, et al.
Publicado: (2021)

Impact of a Statewide Livestock Antibiotic Use Policy on Resistance in Human Urine Escherichia coli Isolates: A Synthetic Control Analysis
por: Casey, Joan A., et al.
Publicado: (2023)

ANTIMICROBIAL RESISTANCE OF ESCHERICHIA COLI STRAINS ISOLATED FROM URINE AT OUTPATIENT POPULATION: A SINGLE LABORATORY EXPERIENCE
por: Vranic, Sabina Mahmutovic, et al.
Publicado: (2016)

PB2225: ENVIRONMENTAL MODIFIERS OF SEVERITY IN CHILDREN WITH SICKLE CELL DISEASE: A FEASIBILITY PILOT STUDY
por: Strouse, J., et al.
Publicado: (2022)

123. Treatment Patterns and Prevalence of Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the US
por: Wang, Yuexi, et al.
Publicado: (2020)

2225. Acute Hepatitis C Virus Infections in HIV-Infected Persons in the Era of Direct-Acting Antiviral Therapy
por: Cartwright, Emily J, et al.
Publicado: (2018)

Exercise-induced bronchoconstriction: prevalence, pathophysiology, patient impact, diagnosis and management
por: Aggarwal, Bhumika, et al.
Publicado: (2018)

Unmet needs in uncomplicated urinary tract infection in the United States and Germany: a physician survey
por: O’Brien, Megan, et al.
Publicado: (2023)

The Effect of Urine Concentration and pH on the Growth of Escherichia Coli in Canine Urine In Vitro
por: Thornton, L.A., et al.
Publicado: (2018)

1480. Plasma and Urine Pharmacokinetic Analysis of Gepotidacin (GSK2140944) Following BID Oral Dosing in a Phase IIa Study for Treatment of Uncomplicated Urinary Tract Infections
por: Zimmerman, Eric I, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8dradu3prgtjg1k964kokjmrec